Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

Détails

ID Serval
serval:BIB_20474C8ED3B1
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.
Périodique
The EMBO journal
Auteur⸱e⸱s
Peli J., Schröter M., Rudaz C., Hahne M., Meyer C., Reichmann E., Tschopp J.
ISSN
0261-4189
Statut éditorial
Publié
Date de publication
1999
Peer-reviewed
Oui
Volume
18
Numéro
7
Pages
1824-31
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't - Publication Status: ppublish
Résumé
Tumor growth is the result of deregulated tissue homeostasis which is maintained through the delicate balance of cell growth and apoptosis. One of the most efficient inducers of apoptosis is the death receptor Fas. We report here that oncogenic Ras (H-Ras) downregulates Fas expression and renders cells of fibroblastic and epitheloid origin resistant to Fas ligand-induced apoptosis. In Ras-transformed cells, Fas mRNA is absent. Inhibition of DNA methylation restores Fas expression. H-Ras signals via the PI 3-kinase pathway to downregulate Fas, suggesting that the known anti-apoptotic effect of the downstream PKB/Akt kinase may be mediated, at least in part, by the repression of Fas expression. Thus, the oncogenic potential of H-ras may reside on its capacity not only to promote cellular proliferation, but also to simultaneously inhibit Fas-triggered apoptosis.
Mots-clé
1-Phosphatidylinositol 3-Kinase, 3T3 Cells, Animals, Antigens, CD95, Apoptosis, Cell Line, DNA Methylation, Down-Regulation, Enzyme Activation, Fas Ligand Protein, Female, Genes, ras, Humans, Membrane Glycoproteins, Mice, Mutation, Transfection, Transformation, Genetic, ras Proteins
Pubmed
Web of science
Open Access
Oui
Création de la notice
24/01/2008 16:19
Dernière modification de la notice
20/08/2019 13:56
Données d'usage